Xolair (omalizumab) is a prescription drug used to treat certain conditions, such as asthma or food allergies. The drug comes as an injection. It’s usually given once every 2 or 4 weeks.

New Delhi: The US Food and Drug Administration (FDA) has approved Omalizumab, which is sold under the brand name Xolair, to treat severe food allergies — making it the first drug to get ...

The approved dose is 300 mg by subcutaneous injection every four weeks. "The EU approval of Xolair in CSU is truly exciting for patients with this chronic and debilitating skin disease," said ...

Xolair (omalizumab) generated revenues of more ... which is available in markets in the US and EU as a subcutaneous injection lasting a few minutes, instead of a lengthy infusion.

Joshua Cohen is a Boston-based writer who covers health policy. Two weeks ago, the Food and Drug Administration approved Xolair (omalizumab) for immunoglobulin E-mediated food allergy in certain ...

Ralshree Go8 Roche's Xolair prefilled syringe self-injection application accepted by US FDA In-depth review of Nature sub-journal: How to develop anti-agin ...